Jared Whitlock
Reporter
Phone: 858-634-4636 Extension: 3130
Recent Stories
Scripps Research Leading International Partnership For HIV Vaccine
NIH Division Will Provide Grant of $129 Million
An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.
These San Diego Biotechs Fell Hard, But Managed to Bounce Back
Biotechs recover momentum after being written off
Once pegged as goners, San Diego life sciences companies like Neurocrine, Arena Pharmaceuticals and Tandem Diabetes Care made comebacks. Their stories shed light on how to weather an industry in which companies expand and contract like an accordion based on clinical trial results.
Palomar, Graybill Medical Look at Possible Affliation
Graybill Medical Group and Palomar recently agreed to negotiate a formal affiliation agreement, a move that Palomar says isn’t so much about competition but nonetheless could ripple through North County’s health-care landscape.
Illumina Expands Startup Accelerator Program to the U.K.
An Illumina program that mentors and invests in early-stage genomics companies is expanding to the U.K.
Startups Claim Slice of a Changing Medical Device Market
HEALTH: $800 Billion Market Is Expected By 2030
The news coming out of San Diego’s medical device scene usually centers on the big dogs: Dexcom, ResMed and Nuvasive.
Alliance Healthcare Foundation Hires New Executive Director
Sarah Lyman has been hired as the executive director of the Alliance Healthcare Foundation, a nonprofit that provides grants to nonprofits that boost health care access for those in need.
Cradle Genomics Lands $17.1M Series A Round for Prenatal Testing
A startup led by former Illumina executives that wants to advance prenatal testing recently landed a $17.1 million series A round.
Trefoil Therapeutics Secures $28M Series A Round
San Diego biotech Trefoil Therapeutics recently brought in a $28 million series A round for work on vision diseases.
Analysts Stick By Illumina After Stock Sell-Off
Illumina analysts are still bullish on the company after a lowered revenue estimate prompted a stock sell-off.
StemoniX’s Growth Pushes It Into New Larger Facility
Its microOrgan Platform Provides More Human-Like Testing Opportunities
StemoniX — a San Diego biotech that grows micro organs from stem cells for drug testing — moved into a larger research facility this month.
